{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Ocala",
      "address_1": "1210 SW 33rd Avenue",
      "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.",
      "address_2": "",
      "product_quantity": "197 units",
      "code_info": "Rx #'s:  0400830    0400830    0403915    0369559    0382655                                0355231    0363469    0364194    0364586    0365232    0368229      0368502            0368575    0379338    0379547        0383465    0387854      0389349      0390953      0391076      0392073    0394447    0394682    0394934    0395429    0395951      0396729    0397109    0397667    0404203    0404799    0405703    0406025    0408991    0359179    0359179    0348862    0356877    0360153    0363384    0363885    0364194    0364239    0366032      0366271    0368245        0368882    0376169    0380550      0382237    0384296    0385288    0387375    0387380        0387486    0388896    0389392    0390771    0392073      0394447    0399970    0399989    0403141    0403755      0405329    0365743    0384729    0389303      0396299      0353130    0355933    0356625    0362693    0363384    0363667    0368575      0368882      0371797      0375692    0380344    0383379    0387330      0387486    0388896    0392336    0392543    0395951    0396870    0402552    0409017    0375411    0395390    0358612    0362693    0366271    0371046    0375511    0375514    0375515    0375518    0375519    0375692    0384296      0387483    0392020    0392336    0408625    0376091      0399724    0356877    0405109    0408823    0362693    0371046    0375356        0375503      0375504      0375506      0375507    0375510      0375511    0375514    0375515    0375518    0375519    0392020      0392336    0396870    0398875    0368836    0354413    0398562    0354048    0389058    0389206      0405941    0358048    0387432    0402040    0391715    0391715    0393524    0404316    0391708    0402008      0391708",
      "center_classification_date": "20120810",
      "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies",
      "state": "FL",
      "product_description": "CEFTAZIDIME OPHTHALMIC, P.F. 22.5MG/ML (2.25%) OPHTHALMIC 1 ML, 2ML, 2 MLS, 6 ML  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  CEFTAZIDIME, LYOPHILIZED, OPHTHALMIC KIT 2.25% KIT\t1 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t12 KIT  \t16 KIT  \t2 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t2 KITS  \t  \t20 KIT  \t  \t  \t  \t3 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t3 KITS  \t  \t4 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t4 KITS  \t  \t4 VIALS  \t5 KIT  \t  \t  \t6 KIT  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t  \t6 VIAL  \t8 KIT  \t  CEFTAZIDIME, SDPF - (0.2ML SYRINGE, 30G, 1/2\") 2.25% INJECTABLE\t0.2 ML  \t  \t  \t  \t  \t0.4 ML  \t  \t  \t0.6 ML  \t0.8 ML  \t  \t  \t1.2 ML  \t  \t  \t1.6 ML (25 DIFFERENT PRODUCTS)",
      "report_date": "20120822",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab",
      "recall_number": "D-1482-2012",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "62416",
      "termination_date": "20140813",
      "more_code_info": "",
      "recall_initiation_date": "20120525",
      "postal_code": "34474-5138",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}